Refractory coeliac disease (RCD) is a very rare and dangerous form of CD, in which gluten-free diet loses its therapeutic effect and the damage of intestinal mucosa persists. Because of the adherence to the diet, serological markers of CD [immunoglobulin A (IgA) antibodies against gliadin, tissue transglutaminase (tTG) and endomysium] are often missing in RCD patients. We found substantially elevated levels of IgA anti-calreticulin (CRT) antibodies in the sera of almost all RCD patients tested. These sera were negative for IgA antibodies to gliadin and tTG and only some of them showed IgA antibodies to enterocytes. Analysis of patients' IgA reactivity to CRT fragments (quarters and halves) by Western blotting revealed differences in the specificity of IgA antibodies between RCD and CD patients. We therefore used the Pepscan technique with synthetic overlapping decapeptides of CRT to characterize antigenic epitopes recognized by serum IgA antibodies of RCD patients. Employing this method we demonstrated several dominant antigenic epitopes recognized by IgA antibodies of RCD patients on the CRT molecule. Epitope GVTKAAEKQMKD was recognized predominantly by serum IgA of RCD patients. Our results suggest that testing for serum IgA antibodies against CRT and its selected peptide could be a very useful tool in RCD differential diagnosis.

Department of Immunology Institute of Microbiology Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology. 2000;119:234–42. PubMed

Green PH, Jabri B. Coeliac disease. Lancet. 2003;362:383–91. PubMed

Londei M, Ciacci C, Ricciardelli I, Vacca L, Quaratino S, Maiuri L. Gliadin as a stimulator of innate response in celiac disease. Mol Immunol. 2005;42:913–18. PubMed

Daum S, Cellier C, Mulder CJJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol. 2005;19:413–24. PubMed

Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet. 2000;356:203–8. PubMed

Biagi F, Corazza GR. Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol. 2001;13:561–5. PubMed

Al-Toma A, Verbeek WHM, Hadithi M, von Blomberg BME, Mulder CJJ. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut. 2007;56:1373–8. PubMed PMC

Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol. 2000;18:795–803. PubMed

Howdle PD, Jalal PK, Holmes GKT, Houlston RS. Primary small-bowel malignancy in the UK and its association with coeliac disease. Q J Med. 2003;96:345–53. PubMed

Cellier C, Brousse N, Cerf-Bensussan N. Classification and outcome of refractory sprue. In: Cerf-Bensussan N, Brousse N, Caillat-Zucman S, Cellier C, Schmitz J, editors. Coeliac disease. Montrouge: John Libbey Eurotext Publishers; 2003. pp. 215–23.

Meijer JW, Mulder CJJ, Goerres MG, Boot H, Schweizer JJ. Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol Suppl. 2004;241:78–84. PubMed

Di Domenico MR, Annaluisa S, Pluvio R, Iovine C, Rea F. The role of anti-endomysium and anti-transglutaminase antibodies in the diagnosis and follow-up of celiac disease. Pediatr Med Chir. 2002;24:208–12. PubMed

Wahab PJ, Meijer JW, Mulder CJJ. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol. 2002;118:459–63. PubMed

Rolny P, Sigurjonsdottir HA, Remotti H, et al. Role of immunosuppressive therapy in refractory sprue-like disease. Am J Gastroenterol. 1999;94:219–25. PubMed

Fliegel L, Burns K, MacLennan DH, Reithmeier RAF, Michalak M. Molecular cloning of the high affinity calcium-binding protein (calreticulin) of skeletal muscle sarcoplasmic reticulum. J Biol Chem. 1989;264:21522–8. PubMed

Smith MJ, Koch GL. Multiple zones in the sequence of calreticulin (CRP55, calregulin, HACBP), a major calcium binding protein ER/SR protein. EMBO J. 1989;8:3581–6. PubMed PMC

Krause KH, Michalak M. Calreticulin. Cell. 1997;88:439–43. PubMed

Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M. Calreticulin: one protein, one gene, many functions. Biochem J. 1999;344:281–92. PubMed PMC

Gelebart P, Opas M, Michalak M. Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum. Int J Biochem Cell Biol. 2000;37:260–6. PubMed

Sánchez D, Tučková L, Šebo P, et al. Occurrence of IgA and IgG autoantibodies to calreticulin in coeliac disease and various autoimmune diseases. J Autoimmun. 2000;15:441–9. PubMed

Sánchez D, Tučková L, Mothes T, Kreisel W, Beneš Z, Tlaskalová-Hogenová H. Epitopes of calreticulin recognised by IgA autoantibodies from patients with hepatic and coeliac disease. J Autoimmun. 2003;21:383–92. PubMed

Walker-Smith JA, Guadalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Report of working group of European Society of Pediatric Gastroenterology and. Nutrition. Arch Dis Child. 1990;65:909–11. PubMed PMC

Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185–94. PubMed

Al-Toma A, Verbeek WHM, Mulder CJJ. Update on the management of refractory coeliac disease. J Gastroitestin Liver Dis. 2007;16:57–63. PubMed

Cellier C, Patey N, Mauvieux L, et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology. 1998;114:471–81. PubMed

Daum S, Hummel H, Weiss D, et al. Refractory sprue syndrome with clonal intraepithelial lymphocytes evolving into overt enteropathy-type intestinal T-cell lymphoma. Digestion. 2000;62:60–5. PubMed

Rongey C, Micallef I, Smyrk T, Murray J. Successful treatment of enteropathy-associated T-cell lymphoma with autologous stem cell transplant. Dig Dis Sci. 2006;51:1082–86. PubMed

Laemmli UK, Favre M. Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol. 1973;80:575–99. PubMed

Michalak M. Calreticulin. Austin: R. G. Landes Company; 1996.

Krupičková S, Tučková L, Flegelová Z, et al. Identification of common epitopes on gliadin, enterocytes, and calreticulin recognised by antigliadin antibodies of patients with coeliac disease. Gut. 1999;44:168–73. PubMed PMC

Højrup P, Roepstorff P, Houen G. Human placental calreticulin characterization of domain structure and post-translational modifications. Eur J Biochem. 2001;268:2558–65. PubMed

Tan Y, Chen M, Li Z, Mabuchi K, Bouvier M. The calcium- and zinc-responsive regions of calreticulin reside strictly in the N-/C-domain. Biochim Biophys Acta. 2006;1760:745–53. PubMed

Ogden CA, deCathelineau A, Hoffmann PR, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001;194:781–95. PubMed PMC

Pittoni V, Valesini G. The clearance of apoptotic cells: implications for autoimmunity. Autoimmun Rev. 2002;1:154–61. PubMed

Ghebrehiwet B, Peerschke EI. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol Immunol. 2004;41:173–83. PubMed

Diosdado B, van Oort E, Wijmenga C. Coelionomics’: towards understanding the molecular pathology of coeliac disease. Clin Chem Lab Med. 2005;43:685–95. PubMed

Eggleton P, Llewellyn DH. Pathophysiological roles of calreticulin in autoimmune disease. Scand J Immunol. 1999;49:466–73. PubMed

Obeid M, Tesniere A, Ghiringhelli F, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med. 2007;13:54–61. PubMed

Basu S, Srivastava PK. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J Exp Med. 1999;189:797–802. PubMed PMC

Eggleton P. Stress protein–polypeptide complexes acting as autoimmune triggers. Clin Exp Immunol. 2003;134:6–8. PubMed PMC

Staikou EV, Routsias JG, Makri AA, et al. Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies. Clin Exp Immunol. 2003;134:143–50. PubMed PMC

Contribution of Infectious Agents to the Development of Celiac Disease

Calreticulin is a B cell molecular target in some gastrointestinal malignancies